Osteoprotective effects of flavonoids: Evidence from in vivo and in vitro studies (Review)

Lili Cao,Jiawei Wang,Yujuan Zhang,Feng Tian,Chunfang Wang
DOI: https://doi.org/10.3892/mmr.2022.12716
IF: 3.423
2022-04-26
Molecular Medicine Reports
Abstract:Osteoporosis is a systemic bone disease characterized by decreased bone mass and quality and bone micro‑architecture degradation. Its primary cause is disorder of bone metabolism: Over‑formation of osteoclasts, resulting in increased bone resorption and insufficient osteogenesis. Traditional herbal flavonoids can be used as alternative drugs to prevent and treat osteoporosis due to their wide range of sources, structural diversity and less adverse effects. The present paper reviewed six flavonoids, including quercetin, icariin, hesperitin, naringin, chrysin and pueraria, that promote bone formation and have been widely studied in the literature over the past five years, with the aim of providing novel ideas for the development of drugs for bone‑associated disease.
oncology,medicine, research & experimental
What problem does this paper attempt to address?